Spinal astrocyte-derived interleukin-17A promotes pain hypersensitivity in bone cancer mice

Spinal microglia and astrocytes are both involved in neuropathic and inflammatory pain, which may display sexual dimorphism. Here, we demonstrate that the sustained activation of spinal astrocytes and astrocyte-derived interleukin (IL)-17A promotes the progression of mouse bone cancer pain without s...

Full description

Saved in:
Bibliographic Details
Main Authors: Huizhu Liu, Xuejing Lv, Xin Zhao, Lanxing Yi, Ning Lv, Wendong Xu, Yuqiu Zhang
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Acta Pharmaceutica Sinica B
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2211383524003812
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846117945445449728
author Huizhu Liu
Xuejing Lv
Xin Zhao
Lanxing Yi
Ning Lv
Wendong Xu
Yuqiu Zhang
author_facet Huizhu Liu
Xuejing Lv
Xin Zhao
Lanxing Yi
Ning Lv
Wendong Xu
Yuqiu Zhang
author_sort Huizhu Liu
collection DOAJ
description Spinal microglia and astrocytes are both involved in neuropathic and inflammatory pain, which may display sexual dimorphism. Here, we demonstrate that the sustained activation of spinal astrocytes and astrocyte-derived interleukin (IL)-17A promotes the progression of mouse bone cancer pain without sex differences. Chemogenetic or pharmacological inhibition of spinal astrocytes effectively ameliorates bone cancer-induced pain-like behaviors. In contrast, chemogenetic or optogenetic activation of spinal astrocytes triggers pain hypersensitivity, implying that bone cancer-induced astrocytic activation is involved in the development of bone cancer pain. IL-17A expression predominantly in spinal astrocytes, whereas its receptor IL-17 receptor A (IL-17RA) was mainly detected in neurons expressing VGLUT2 and PAX2, and a few in astrocytes expressing GFAP. Specific knockdown of IL-17A in spinal astrocytes blocked and delayed the development of bone cancer pain. IL-17A overexpression in spinal astrocytes directly induced thermal hyperalgesia and mechanical allodynia, which could be rescued by CaMKIIα inhibitor. Moreover, selective knockdown IL-17RA in spinal Vglut2+ or Vgat+neurons, but not in astrocytes, significantly blocked the bone cancer-induced hyperalgesia. Together, our findings provide evidence for the crucial role of sex-independent astrocytic signaling in bone cancer pain. Targeting spinal astrocytes and IL-17A/IL-17RA-CaMKIIα signaling may offer new gender-inclusive therapeutic strategies for managing bone cancer pain.
format Article
id doaj-art-fae11f272a9f4e009a22c8632b8c69f4
institution Kabale University
issn 2211-3835
language English
publishDate 2024-12-01
publisher Elsevier
record_format Article
series Acta Pharmaceutica Sinica B
spelling doaj-art-fae11f272a9f4e009a22c8632b8c69f42024-12-18T08:48:46ZengElsevierActa Pharmaceutica Sinica B2211-38352024-12-01141252495266Spinal astrocyte-derived interleukin-17A promotes pain hypersensitivity in bone cancer miceHuizhu Liu0Xuejing Lv1Xin Zhao2Lanxing Yi3Ning Lv4Wendong Xu5Yuqiu Zhang6Department of Translational Neuroscience, Jing’an District Centre Hospital of Shanghai, Institutes of Brain Science, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Fudan University, Shanghai 200032, ChinaDepartment of Translational Neuroscience, Jing’an District Centre Hospital of Shanghai, Institutes of Brain Science, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Fudan University, Shanghai 200032, ChinaDepartment of Translational Neuroscience, Jing’an District Centre Hospital of Shanghai, Institutes of Brain Science, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Fudan University, Shanghai 200032, ChinaDepartment of Translational Neuroscience, Jing’an District Centre Hospital of Shanghai, Institutes of Brain Science, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Fudan University, Shanghai 200032, ChinaDepartment of Translational Neuroscience, Jing’an District Centre Hospital of Shanghai, Institutes of Brain Science, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Fudan University, Shanghai 200032, China; Corresponding authors.Department of Translational Neuroscience, Jing’an District Centre Hospital of Shanghai, Institutes of Brain Science, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Fudan University, Shanghai 200032, China; Department of Hand Surgery, Huashan Hospital, Fudan University, Shanghai 200040, China; Corresponding authors.Department of Translational Neuroscience, Jing’an District Centre Hospital of Shanghai, Institutes of Brain Science, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Fudan University, Shanghai 200032, China; Corresponding authors.Spinal microglia and astrocytes are both involved in neuropathic and inflammatory pain, which may display sexual dimorphism. Here, we demonstrate that the sustained activation of spinal astrocytes and astrocyte-derived interleukin (IL)-17A promotes the progression of mouse bone cancer pain without sex differences. Chemogenetic or pharmacological inhibition of spinal astrocytes effectively ameliorates bone cancer-induced pain-like behaviors. In contrast, chemogenetic or optogenetic activation of spinal astrocytes triggers pain hypersensitivity, implying that bone cancer-induced astrocytic activation is involved in the development of bone cancer pain. IL-17A expression predominantly in spinal astrocytes, whereas its receptor IL-17 receptor A (IL-17RA) was mainly detected in neurons expressing VGLUT2 and PAX2, and a few in astrocytes expressing GFAP. Specific knockdown of IL-17A in spinal astrocytes blocked and delayed the development of bone cancer pain. IL-17A overexpression in spinal astrocytes directly induced thermal hyperalgesia and mechanical allodynia, which could be rescued by CaMKIIα inhibitor. Moreover, selective knockdown IL-17RA in spinal Vglut2+ or Vgat+neurons, but not in astrocytes, significantly blocked the bone cancer-induced hyperalgesia. Together, our findings provide evidence for the crucial role of sex-independent astrocytic signaling in bone cancer pain. Targeting spinal astrocytes and IL-17A/IL-17RA-CaMKIIα signaling may offer new gender-inclusive therapeutic strategies for managing bone cancer pain.http://www.sciencedirect.com/science/article/pii/S2211383524003812AstrocyteMicrogliaInterleukin-17ASex differenceChemogenetic manipulationOptogenetic manipulation
spellingShingle Huizhu Liu
Xuejing Lv
Xin Zhao
Lanxing Yi
Ning Lv
Wendong Xu
Yuqiu Zhang
Spinal astrocyte-derived interleukin-17A promotes pain hypersensitivity in bone cancer mice
Acta Pharmaceutica Sinica B
Astrocyte
Microglia
Interleukin-17A
Sex difference
Chemogenetic manipulation
Optogenetic manipulation
title Spinal astrocyte-derived interleukin-17A promotes pain hypersensitivity in bone cancer mice
title_full Spinal astrocyte-derived interleukin-17A promotes pain hypersensitivity in bone cancer mice
title_fullStr Spinal astrocyte-derived interleukin-17A promotes pain hypersensitivity in bone cancer mice
title_full_unstemmed Spinal astrocyte-derived interleukin-17A promotes pain hypersensitivity in bone cancer mice
title_short Spinal astrocyte-derived interleukin-17A promotes pain hypersensitivity in bone cancer mice
title_sort spinal astrocyte derived interleukin 17a promotes pain hypersensitivity in bone cancer mice
topic Astrocyte
Microglia
Interleukin-17A
Sex difference
Chemogenetic manipulation
Optogenetic manipulation
url http://www.sciencedirect.com/science/article/pii/S2211383524003812
work_keys_str_mv AT huizhuliu spinalastrocytederivedinterleukin17apromotespainhypersensitivityinbonecancermice
AT xuejinglv spinalastrocytederivedinterleukin17apromotespainhypersensitivityinbonecancermice
AT xinzhao spinalastrocytederivedinterleukin17apromotespainhypersensitivityinbonecancermice
AT lanxingyi spinalastrocytederivedinterleukin17apromotespainhypersensitivityinbonecancermice
AT ninglv spinalastrocytederivedinterleukin17apromotespainhypersensitivityinbonecancermice
AT wendongxu spinalastrocytederivedinterleukin17apromotespainhypersensitivityinbonecancermice
AT yuqiuzhang spinalastrocytederivedinterleukin17apromotespainhypersensitivityinbonecancermice